Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company

Dear shareholder,

Dear Madam, Dear Sir,


please find attached our press release.


Best regards

Ackermans & van Haaren

Attachment

  • Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics (press release 26 July 2024)

Ackermans and Van Haaren... (EU:ACKB)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Ackermans and Van Haaren... Charts.
Ackermans and Van Haaren... (EU:ACKB)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Ackermans and Van Haaren... Charts.